Expert says Medicaid, Medicare reform is critical and can save $2.1 trillion
Surging federal spending on health care programs like Medicare and Medicaid, as well as ObamaCare, prompted Paragon's plan to curb spending by an estimated $2.1 trillion over 10 years.
Expert discusses need for federal health care policy reforms
Paragon Health Institute's Brian Blase discusses strategies for reforming major federal health care programs.
Baby powder sold on Amazon recalled due to potential asbestos contamination
Dynarex Corp. is recalling 62 cases of its Dynacare Baby Powder after sample testing revealed that the finished product contained asbestos, a known carcinogen.
Pesticides in our food have become a ‘blind spot’ in our health: Dr. Marty Makary
Johns Hopkins School of Medicine professor Dr. Marty Makary reacts to a new report revealing that cancer deaths in the U.S. fell by 33% in 30 years.
AI-powered app offers personalized allergy forecasts
SoundHealth launched a new feature in its AI-powered health care app that will give users personalized allergy forecasts to get ahead of their symptoms.
Inside the production pipeline for new drugs to combat heart failure
Cardiol Therapeutics Inc. President and CEO David Elsley discusses the rise in heart failure deaths among young adults on 'Making Money.'
Study: COVID accelerated aging in teens' brains
Johns Hopkins School of Medicine professor Dr. Marty Makary joins 'Varney & Co.' to discuss a new study that shows the impact the COVID pandemic had on teenagers' brains.
Weight-loss drugs and children: What doctors say about the safety, effectiveness of the medications
Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being tested on children as young as six years old.
Daily exercise is better than taking a shot to combat obesity: Dr. Marc Siegel
Fox News senior medical analyst Dr. Marc Siegel discusses whether weight-loss drugs are safe for children on 'The Big Money Show.'
Doctors draw attention to safety issues associated with popular weight-loss drugs
The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents a shift in obesity management.
Weight-loss drugs could reduce COVID-related deaths: Study
A new study found that weekly injections of 2.4 mg of semaglutide could lower the risk of deaths related to COVID-19, marking another potential benefit of these blockbuster drugs.
Eli Lilly cuts cost of certain Zepbound doses by at least 50%
Eli Lilly is launching more supply of its weight loss drug Zepbound. The new single-dose vials will be priced lower than "all other incretin GLP-1 medicines for obesity."
Eli Lilly's Zepbound reduces type 2 diabetes risk, study shows
Eli Lilly announced results of a study in which weekly shots of tirzepatide injections significantly reduced the risk of progression to type 2 diabetes by 94% among certain adults.
Novo Nordisk slashes outlook even as it ramps up Wegovy production
Danish drug maker Novo Nordisk lowered its full year forecast even as tens of thousands of patients start the highly coveted weight loss drug, Wegovy, every week.
Nearly 7,000 pounds of hot dogs recalled due to lack of inspection
Thousands of pounds of hot dogs are being recalled after officials discovered that they were produced and shipped to restaurants and hotels without being federally inspected.
Study reveals smoking contributes to 30% of cancer deaths
Fox News senior correspondent Jonathan Serrie reports on a promising new study from the American Cancer Society researching various prevention methods.
Dr. Marc Siegel issues a warning to summertime swimmers amid a surge of pool illnesses
Fox News medical contributor Dr. Marc Siegel weighs in on Eli Lilly’s Alzheimer’s drug and breaks down the most common pool-related illnesses.
Charles Payne: Biden should not beat up Big Pharma for making money
'Making Money' host Charles Payne reacts to Biden calling on Novo Nordisk and Eli Lilly to cut weight loss drug prices.
Supreme Court blocks bankruptcy deal for OxyContin maker Purdue Pharma
The U.S. Supreme Court on Thursday struck down Purdue Pharma's nationwide settlement agreement, delaying compensation for opioid victims.
Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing
Novo Nordisk is ramping up the manufacturing capacity of its obesity-related drugs as demand for Wegovy and Ozempic continues to surge. It's pouring $4.1 billion to expand its facility.